B2A Trademark

Trademark Overview

On Wednesday, April 5, 2023, a trademark application was filed for B2A with the United States Patent and Trademark Office. The USPTO has given the B2A trademark a serial number of 97873730. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 27, 2024. This trademark is owned by Ferring B.V.. The B2A trademark is filed in the Medical Instrument Products category with the following description:

Synthetic growth-factor analog peptide products, namely, peptide coated bone graft substitutes for filling voids and gaps in bone including those of the vertebral column, for use with invasive and other medical procedures
b2a

General Information

Serial Number97873730
Word MarkB2A
Filing DateWednesday, April 5, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements

Pseudo MarkB TWO A
Goods and ServicesSynthetic growth-factor analog peptide products, namely, peptide coated bone graft substitutes for filling voids and gaps in bone including those of the vertebral column, for use with invasive and other medical procedures

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 1, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Saturday, April 8, 2023NEW APPLICATION ENTERED
Tuesday, January 2, 2024ASSIGNED TO EXAMINER
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 18, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 18, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

peptide bone those including gaps vertebral invasive procedures medical other